Suppr超能文献

己酸羟孕酮及其与他莫昔芬联合应用对子宫体癌患者肿瘤中甾体激素受体及生殖内环境基本参数的影响

[The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].

作者信息

Vishnevskiĭ A S, Bokhman Ia V, Tsyrlina E V, Bobrov Iu F, Shtofmakher I A

出版信息

Vopr Onkol. 1989;35(9):1063-7.

PMID:2815695
Abstract

Oxyprogesterone capronate (OPC) was administered preoperatively to 46 patients with endometrial tumors and tamoxifen (T) + OPC--to 72 patients. Complex treatment was followed by more pronounced pathomorphosis in tumor. Both schedules inhibited gonadotropin secretion and lowered colpocytoscopic indexes. Dual effect of complex treatment (T + OPC) on the level of cytoplasmic receptors to progesterone was observed. Initially low levels rose while high ones dropped by the end of a 20-day course. Progestin treatment in endometrial carcinoma patients with relatively low estrogen levels should be complemented with tamoxifen to stimulate tumor sensitivity to progestagens.

摘要

术前对46例子宫内膜肿瘤患者给予己酸羟孕酮(OPC),对72例患者给予他莫昔芬(T)+OPC。综合治疗后肿瘤出现更明显的病理形态改变。两种方案均抑制促性腺激素分泌并降低阴道细胞学指数。观察到综合治疗(T+OPC)对孕酮细胞质受体水平有双重作用。最初较低的水平升高,而较高的水平在20天疗程结束时下降。对于雌激素水平相对较低的子宫内膜癌患者,孕激素治疗应辅以他莫昔芬以刺激肿瘤对孕激素的敏感性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验